US2018318192A1PendingUtilityA1

Glyceryl and glycol acid compounds

66
Assignee: MARY KAY INCPriority: May 19, 2006Filed: Jul 11, 2018Published: Nov 8, 2018
Est. expiryMay 19, 2026(expired)· nominal 20-yr term from priority
Inventors:Anton A. MentlikJames Swanzy
A61P 17/00A61Q 19/007A61Q 19/08A61K 8/375A61Q 17/04A61K 8/06A61K 8/0216A61K 8/37A61Q 19/00
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a topical skin composition comprising a glycol di-salicylate or a glycol di-benzoate compound having the following structure: where R is OH or H, n is 1 or 2, and where the composition further includes a glycol mono-salicylate compound or a glycol mono-benzoate compound.

Claims

exact text as granted — not AI-modified
1 . A topical skin composition comprising a glycol di-salicylate or a glycol di-benzoate compound having the following structure: 
       
         
           
           
               
               
           
         
         where R is OH or H, 
         n is 1 or 2, and 
         where the composition further includes a glycol mono-salicylate compound or a glycol mono-benzoate compound. 
       
     
     
         2 . The topical skin composition of  claim 1 , wherein the composition is an emulsion. 
     
     
         3 . The topical skin composition of  claim 2 , wherein the composition is an oil-in-water emulsion. 
     
     
         4 . The topical skin composition of  claim 2 , wherein the composition is a water-in-oil emulsion. 
     
     
         5 . The topical skin composition of  claim 1 , wherein the composition is a cream, a lotion, or an ointment. 
     
     
         6 . The topical skin composition of  claim 1 , wherein the composition is a gel. 
     
     
         7 . The topical skin composition of  claim 1 , wherein the composition is a solution. 
     
     
         8 . The topical skin composition of  claim 1 , wherein the composition comprises from about 0.001 to about 20%, by weight, of the glyceryl di-salicylate. 
     
     
         9 . The topical skin composition of  claim 1 , comprising the glycol di-salicylate compound, where R is OH and n is 1. 
     
     
         10 . The topical skin composition of  claim 9 , comprising the glycol mono-salicylate compound having the following structure: 
       
         
           
           
               
               
           
         
       
     
     
         11 . The topical skin composition of  claim 1 , comprising the glycol di-benzoate compound, where R is H and n is 1. 
     
     
         12 . The topical skin composition of  claim 11 , comprising the glycol mono-benzoate compound having the following structure:

Join the waitlist — get patent alerts

Track US2018318192A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.